Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 8, 2010, Pages 3287-3292

  Borselli, Cristina ^a,b   Storrie, Hannah ^a   Benesch Lee, Frank ^c,d   Shvartsman, Dmitry ^a   Cezar, Christine ^a   Lichtman, Jeff W ^e   Vandenburgh, Herman H ^c,d   Mooney, David J ^a  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Myomics Inc   (United States)

^d MIRIAM HOSPITAL   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

Alginate; Insulin like growth factor 1; Satellite cells; Tissue engineering; VEGF

Indexed keywords

ALGINIC ACID; KI 67 ANTIGEN; RECOMBINANT SOMATOMEDIN C; RECOMBINANT VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL PROTECTION; CELL STIMULATION; CONTROLLED STUDY; FEMALE; GEL; GRACILIS MUSCLE; HYPOXIA; INFLAMMATION; LIMB ISCHEMIA; MOUSE; MUSCLE CONTRACTILITY; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MUSCLE REGENERATION; MUSCLE REINNERVATION; MYOBLAST; MYOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; SATELLITE CELL; TIBIALIS ANTERIOR MUSCLE; TISSUE NECROSIS; TISSUE PERFUSION;

ANIMALS; CELL PROLIFERATION; FEMALE; INSULIN-LIKE GROWTH FACTOR I; ISCHEMIA; MICE; MICE, INBRED C57BL; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOBLASTS; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RODENTIA;

EID: 77649254893     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0903875106     Document Type: Article

References (58)

1. Chargé SB, Rudnicki MA (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209-238.
2. Tidball JG (2005) Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288:R345-R353.
3. Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9: 493-495.
4. Schultz E, Gibson MC, Champion T (1978) Satellite cells are mitotically quiescent in mature mouse muscle: An EM and radioautographic study. J Exp Zool 206:451-456.
5. Engert JC, Berglund EB, Rosenthal N (1996) Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J Cell Biol 135:431-440.
6. Wagers AJ, Conboy IM (2005) Cellular and molecular signatures of muscle regeneration: Current concepts and controversies in adult myogenesis. Cell 122:659-667.
7. Grounds MD (1998) Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann N Y Acad Sci 854:78-91.
8. Gussoni E, et al. (2002) Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 110:807-814.
9. Lubeck DP (2003) The costs of musculoskeletal disease: Health needs assessment and health economics. Best Pract Res Clin Rheumatol 17:529-539.
10. McClatchey KD (2004) Musculoskeletal conditions affect millions. Arch Pathol Lab Med 128:480.
11. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM (1989) Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337:176-179.
12. Saxena AK, Marler J, Benvenuto M, Willital GH, Vacanti JP (1999) Skeletal muscle tissue engineering using isolated myoblasts on synthetic biodegradable polymers: Preliminary studies. Tissue Eng 5:525-532.
13. Levenberg S, et al. (2005) Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23:879-884.
14. Lee KY, Peters MC, Anderson KW, Mooney DJ (2000) Controlled growth factor release from synthetic extracellular matrices. Nature 408:998-1000.
15. Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19:1029-1034.
16. Silva EA, Mooney DJ (2007) Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 5:590-598.
17. Messina S, et al. (2007) VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice. FASEB J 21:3737-3746.
18. Kärkkäinen AM, et al. (2009) Vascular endothelial growth factor-D transgenic mice show enhanced blood capillary density, improved postischemic muscle regeneration, and increased susceptibility to tumor formation. Blood 113:4468-4475.
19. Deasy BM, et al. (2009) Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther 17:1788-1798.
20. Dellavalle A, et al. (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9:255-267.
21. Zheng B, et al. (2007) Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 25:1025-1034.
22. Crisan M, et al. (2008) Purification and culture of human blood vessel-associated progenitor cells. Curr Protoc Stem Cell Biol Unit 2B.2.1-2B.2.13.
23. Ferrari G, et al. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530.
24. LaBarge MA, Blau HM (2002) Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111:589-601.
25. Hill E, Boontheekul T, Mooney DJ (2006) Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci USA 103:2494-2499.
26. Tidball JG (2005) Mechanical signal transduction in skeletal muscle growth and adaptation. J Appl Physiol 98:1900-1908.
27. Heszele MF, Price SR (2004) Insulin-like growth factor I: The yin and yang of muscle atrophy. Endocrinology 145:4803-4805.
28. Shansky J, Creswick B, Lee P, Wang X, Vandenburgh H (2006) Paracrine release of insulin-like growth factor 1 from a bioengineered tissue stimulates skeletal muscle growth in vitro. Tissue Eng 12:1833-1841.
29. Conway EM, Collen D, Carmeliet P (2001) Molecular mechanisms of blood vessel growth. Cardiovasc Res 49:507-521.
30. Khurana R, Simons M, Martin JF, Zachary IC (2005) Role of angiogenesis in cardiovascular disease: A critical appraisal. Circulation 112:1813-1824.
31. Vandenburgh HH, Karlisch P, Shansky J, Feldstein R (1991) Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture. Am J Physiol 260: C475-C484.
32. Musarò A, et al. (2004) Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci USA 101:1206-1210.
33. Pelosi L, et al. (2007) Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J 21:1393-1402.
34. Rosenthal S-M, Cheng Z-Q (1995) Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc Natl Acad Sci USA 92:10307-10311.
35. Bass J, Oldham J, Sharma M, Kambadur R (1999) Growth factors controlling muscle development. Domest Anim Endocrinol 17:191-197.
36. Arsic N, et al. (2004) Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther 10:844-854.
37. Jin KL, Mao XO, Greenberg DA (2000) Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 97:10242-10247.
38. Schratzberger P, et al. (2000) Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat Med 6:405-413.
39. Hawke TJ, Garry DJ (2001) Myogenic satellite cells: Physiology to molecular biology. J Appl Physiol 91:534-551.
40. Adams GR, McCue SA (1998) Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 84:1716-1722.
41. Chakravarthy MV, Davis BS, Booth FW (2000) IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J Appl Physiol 89:1365-1379.
42. Coleman ME, et al. (1995) Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270:12109-12116.
43. Bark TH, McNurlan MA, Lang CH, Garlick PJ (1998) Increased protein synthesis after acute IGF-I or insulin infusion is localized to muscle in mice. Am J Physiol 275: E118-E123.
44. Barton-Davis ER, Shoturma DI, Sweeney HL (1999) Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 167:301-305.
45. Musarò A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N (1999) IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400:581-585.
46. Semsarian C, et al. (1999) Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature 400:576-581.
47. Musarò A, Dobrowolny G, Rosenthal N (2007) The neuroprotective effects of a locally acting IGF-1 isoform. Exp Gerontol 42:76-80.
48. Dobrowolny G, et al. (2005) Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 168:193-199.
49. Dobrowolny G, Aucello M, Molinaro M, Musarò A (2008) Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model. Neurol Res 30:131-136.
50. Mack T-G, et al. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 4:1199-1206.
51. Coleman MP, Ribchester RR (2004) Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system. Curr Drug Targets CNS Neurol Disord 3:227-238.
52. Mourkioti F, Rosenthal N (2005) IGF-1, inflammation and stem cells: Interactions during muscle regeneration. Trends Immunol 26:535-542.
53. Vergani L, et al. (1998) Systemic administration of insulin-like growth factor decreases motor neuron cell death and promotesmuscle reinnervation. J Neurosci Res 54:840-847.
54. Caroni P, Grandes P (1990) Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J Cell Biol 110:1307-1317.
55. Couffinhal T, et al. (1999) Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation 99:3188-3198.
56. Lichtman JW, Sanes JR (2003) Watching the neuromuscular junction. J Neurocytol 32: 767-775.
57. Chen RR, Silva EA, Yuen WW, Mooney DJ (2007) Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24:258-264.
58. Duty S, Allen DG (1994) The distribution of intracellular calcium concentration in isolated single fibres of mouse skeletal muscle during fatiguing stimulation. Pflugers Arch 427:102-109.